Prostacyclin receptor-dependent inhibition of human erythroleukemia cell differentiation is STAT3-dependent.
Lau, Alaster H Y
Prostacyclin receptor-dependent inhibition of human erythroleukemia cell differentiation is STAT3-dependent. [electronic resource] - Prostaglandins, leukotrienes, and essential fatty acids Mar 2012 - 119-26 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1532-2823
10.1016/j.plefa.2011.12.002 doi
Cell Differentiation
Cell Line, Tumor
Cell Survival
Epoprostenol--analogs & derivatives
Humans
Integrin beta3--metabolism
Leukemia, Erythroblastic, Acute--metabolism
Platelet Membrane Glycoprotein IIb--metabolism
Receptors, Epoprostenol--metabolism
STAT3 Transcription Factor--metabolism
Signal Transduction
Tetradecanoylphorbol Acetate--pharmacology
Prostacyclin receptor-dependent inhibition of human erythroleukemia cell differentiation is STAT3-dependent. [electronic resource] - Prostaglandins, leukotrienes, and essential fatty acids Mar 2012 - 119-26 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1532-2823
10.1016/j.plefa.2011.12.002 doi
Cell Differentiation
Cell Line, Tumor
Cell Survival
Epoprostenol--analogs & derivatives
Humans
Integrin beta3--metabolism
Leukemia, Erythroblastic, Acute--metabolism
Platelet Membrane Glycoprotein IIb--metabolism
Receptors, Epoprostenol--metabolism
STAT3 Transcription Factor--metabolism
Signal Transduction
Tetradecanoylphorbol Acetate--pharmacology